Monday, March 31, 2014 7:17:00 PM
My point is, if you're in this for MANF, take a step back and reframe your outlook on AMBS. These day to day swings regarding the progression of LymPro that some seem to get so upset about are trivial in the grand scheme of things. Simply let the company execute it's action plan, which appears to be sound, and don't demand a PR every morning and night. I for one like that Gerald doesn't hyper-actively pump the stock like some CEOs I've seen (i.e., NVIV's ex-CEO) because when expectations inevitably meet reality, those stocks implode (I believe NVIV investors have filed suit against the former CEO). In sum, to put things in perspective, LymPro is the Wednesday par 3 tournament, while MANF is the Masters. I try to keep this in mind.
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM